4.5 Article

B cell-intrinsic TLR7 signaling is required for neutralizing antibody responses to SARS-CoV-2 and pathogen-like COVID-19 vaccines

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Hydroxychloroquine inhibits proteolytic processing of endogenous TLR7 protein in human primary plasmacytoid dendritic cells

Claire Cenac et al.

Summary: The study found that hydroxychloroquine inhibits cleavage of TLR7 protein, leading to accumulation of full-length protein and preventing activation of pDCs in response to TLR7 stimulation. This suggests that hydroxychloroquine may inhibit ssRNA sensing by pDCs through its ability to inhibit endosomal acidification and the functional maturation of TLR7 protein.

EUROPEAN JOURNAL OF IMMUNOLOGY (2022)

Review Multidisciplinary Sciences

Human genetic and immunological determinants of critical COVID-19 pneumonia

Qian Zhang et al.

Summary: SARS-CoV-2 infection is generally mild, but in around 10% of cases, it can lead to severe pneumonia and potentially death. Genetic factors, such as inborn errors of type I interferons, and pre-existing auto-antibodies can increase the risk of critical illness. The production of type I interferons is essential for host defense against the virus.

NATURE (2022)

Article Immunology

Human type I IFN deficiency does not impair B cell response to SARS-CoV-2 mRNA vaccination

Aurelien Sokal et al.

Summary: Intact B cell responses to SARS-CoV-2 mRNA vaccines were observed in patients with genetic or acquired type I IFN deficiencies, indicating that type I IFNs induced by mRNA vaccines are not necessary for vaccine efficacy. This study suggests that the generation of a humoral response against SARS-CoV-2 by mRNA vaccines does not require the induction of type I IFN.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Microbiology

Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells

Rebecca L. Ursin et al.

Summary: Adult females develop stronger antibody responses to influenza vaccines compared to males, and this gender difference is observed in both humans and mice. Females also show better protection against the vaccine virus and mutant strains, with lower virus titers and reduced morbidity. The higher antibody response in females is attributed to the production of class-switched, somatically hypermutated antibodies generated in germinal center B cells, which recognize a greater number of unique hemagglutinin antigen epitopes. The mechanisms underlying female-biased immunity and protection differ between males and females, highlighting the need to consider this gender difference in the development of universal influenza vaccines.
Article Medicine, Research & Experimental

Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein

Lydia Horndler et al.

Summary: This study describes a sensitive and quantitative flow cytometry method for identifying individuals with anti-SARS-CoV-2 immunity, independent of other serological tests or repeated PCR monitoring.

EMBO MOLECULAR MEDICINE (2021)

Article Immunology

Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses

Mohamad-Gabriel Alameh et al.

Summary: Lipid nanoparticle (LNP)-encapsulated nucleoside-modified mRNA vaccines have intrinsic adjuvant activity that enhances durable and protective antibody responses. Compared to the widely used MF59-like adjuvant AddaVax, this LNP formulation outperforms and relies on specific components and cytokine induction for its adjuvant activity.

IMMUNITY (2021)

Article Immunology

SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4

Fanny Onodi et al.

Summary: Studies have shown that human pDCs can be efficiently activated by SARS-CoV-2 particles and may contribute to type I IFN-dependent immunity against SARS-CoV-2 infection.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Immunology

Sex Differences in the Evolution of Neutralizing Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2

Ludivine Grzelak et al.

Summary: In a study of 308 healthcare workers with mild COVID-19, it was found that individuals over 50 years old and with a BMI over 25 kg/m(2) had higher levels of anti-S and anti-N antibodies in the first month. Between months 3-6, 99% of individuals had detectable anti-S antibodies, while 59% had anti-N antibodies. Additionally, anti-S and neutralizing antibodies declined faster in men compared to women, regardless of age and BMI.

JOURNAL OF INFECTIOUS DISEASES (2021)

Article Biology

Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study

Chiara Fallerini et al.

Summary: Loss-of-function variants in TLR7 were found to be associated with severe COVID-19 in young males, representing a subset of male patients and contributing to disease susceptibility in approximately 2% of severe COVID-19 cases. This study provides insight into the genetic factors influencing COVID-19 severity in male patients.
Article Multidisciplinary Sciences

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

Alain Townsend et al.

Summary: Serological detection of antibodies against SARS-CoV-2 is crucial to establish seroconversion rates. Researchers have developed a free red cell agglutination test to detect antibodies against the receptor binding domain for distribution to qualified research groups.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

Flow cytometry detection of sustained humoral immune response (IgG plus IgA) against native spike glycoprotein in asymptomatic/mild SARS-CoV-2 infection

Paula Pinero et al.

Summary: SARS-CoV-2, the virus responsible for COVID-19, has caused the worst pandemic of the century. Serological tests are crucial for evaluating the efficacy of global vaccination efforts. A highly sensitive and specific FCM assay has been developed to detect antibodies against the SARS-CoV-2 S-protein up to 8 months post-infection.

SCIENTIFIC REPORTS (2021)

Article Immunology

Genetic Screening for TLR7 Variants in Young and Previously Healthy Men With Severe COVID-19

Xavier Solanich et al.

Summary: The study found loss-of-function TLR7 variants in young men with severe COVID-19, which may result in weakened interferon responses to the virus. Additionally, siblings of two patients carrying the variants also showed different degrees of disease symptoms, indicating a potential genetic predisposition.

FRONTIERS IN IMMUNOLOGY (2021)

Article Medicine, General & Internal

Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection

Floriane Gallais et al.

Summary: The study revealed a triphasic kinetic model of SARS-CoV-2 antibodies in convalescent individuals, showing long-term persistence and reduced risk of reinfection. Vaccination significantly increased antibody titers, enhancing protection against variants.

EBIOMEDICINE (2021)

Article Immunology

X-linked recessive TLR7 deficiency in ∼1% of men under 60 years old with life-threatening COVID-19

Takaki Asano et al.

Summary: A study revealed that rare X-linked TLR7 variants were found in 16 unrelated male individuals with critical COVID-19 pneumonia out of a cohort of 1202 male patients. No such variants were detected in 331 asymptomatic or mildly infected male individuals.

SCIENCE IMMUNOLOGY (2021)

Article Cell Biology

A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates

Chang Guo et al.

Summary: A synthetic pathogen-like antigen-based COVID-19 vaccine candidate designed to activate B cell antigen receptors and Toll-like receptors shows promising results, inducing robust neutralizing antibodies in mice and non-human primates, accelerating viral clearance in vaccinated animals, and inducing durable memory immune responses.

CELL REPORTS MEDICINE (2021)

Review Immunology

The role of B cell antigen presentation in the initiation of CD4+T cell response

Zhaolin Hua et al.

IMMUNOLOGICAL REVIEWS (2020)

Article Medicine, General & Internal

Presence of Genetic Variants Among Young Men With Severe COVID-19

Caspar I. van der Made et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Multidisciplinary Sciences

Biological sex affects vaccine efficacy and protection against influenza in mice

Ashley L. Fink et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Immunology

TLR7 escapes X chromosome inactivation in immune cells

Melanie Souyris et al.

SCIENCE IMMUNOLOGY (2018)

Review Immunology

Major findings and recent advances in virus like particle (VLP)-based vaccines

Mona O. Mohsen et al.

SEMINARS IN IMMUNOLOGY (2017)

Article Immunology

Guidelines for the use of flow cytometry and cell sorting in immunological studies

Andrea Cossarizza et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2017)